The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Chugai Pharmaceutical Partners with Gero in a Potentially $1B+ Research Collaboration on Age-Related Diseases.
Jul 07, 2025•12 months ago
Contract Type
partnership
TokyoBiotechnologyHealth CarePharmaceutical
Description
Chugai Pharmaceutical is entering a research partnership with AI-driven biotech Gero to tackle age-related diseases, potentially worth over $1 billion. The collaboration will utilize Gero's AI platform for discovering antibody drug candidates targeting these diseases.
Company Information
Company
Chugai Pharmaceutical
Location
Tokyo, Japan
About
Chugai Pharmaceutical is a Tokyo-based biotech firm that specializes in innovative drug discovery and development. It is a majority-owned subsidiary of Roche and is focused on creating novel therapeutic solutions. The company leverages cutting-edge technology and scientific expertise to address unmet medical needs in various therapeutic areas.
Predictive Intelligence
Strategic
ML-powered predictions for Chugai Pharmaceutical's next move
TokyoBiotechnologyHealth CarePharmaceutical